MedPath

Prospective study to evaluate clinico-mycological profile and antifungal drug susceptibility in dermatophytic skin infections

Not Applicable
Completed
Conditions
Health Condition 1: null- Tinea corporis and cruris
Registration Number
CTRI/2018/02/011988
Lead Sponsor
ONE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Forty consenting adult patients with a diagnosis of Tinea cruris and/or corporis, on clinical examination with confirmation by KOH microscopy, who would require systemic treatment as per the assessment of the examining physician and have at least 5 cutaneous lesions shall be included.

Exclusion Criteria

1.Patients who have used any systemic antifungal therapy within the preceding 4 weeks and any topical treatment (antifungals/steroids/combination of the 2) in the preceding 2 weeks shall be excluded.

2.Pregnant/lactating women

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath